RECORDATI: CONTINUING
THE JOURNEY OF PROFITABLE GROWTH
2022 Preliminary Full-Year Results and 2023-2025 Plan Update
Milano, February 21st 2023
SPEAKERS
|
Alberto Martinez |
Luigi La Corte |
Rob Koremans |
Scott Pescatore |
|
Executive VP |
Chief Financial |
Chief Executive |
Executive VP |
|
Specialty & Primary |
Officer |
Officer |
Rare Diseases |
4
AGENDA
2022 preliminary full-year results
Recordati today, strategy and value proposition
- Recordati today
- Strategy and value proposition
Two core businesses
- Specialty & Primary Care
- Rare diseases
2023-2025 Financial projections
Luigi La Corte
Chief Financial Officer
Rob Koremans
Chief Executive Officer
Alberto Martinez
Executive VP
Specialty & Primary Care
Scott Pescatore
Executive VP
Rare Diseases
Rob Koremans
Chief Executive Officer
Allegati
Disclaimer
Recordati Industria Chimica e Farmaceutica S.p.A. ha pubblicato questo contenuto il 21 febbraio 2023 ed è responsabile delle informazioni in esso contenute. Distribuito da Public, senza apportare modifiche o alterazioni, il 21 febbraio 2023 12:30:08 UTC.
